June 9, 2014 — Toshiba America Medical Systems Inc. announced the release of its Celesteion system for positron emission tomography/computed tomography (PET/CT) imaging. The Celesteion is currently pending 510(k) clearance from the U.S. Food and Drug Administration (FDA).
June 9, 2014 — After conducting a functional magnetic resonance imaging (fMRI) study on memory and categorization, researchers have shown for the first time that these mathematical models seem to correctly explain processing in the medial temporal lobes, a region of the brain associated with long-term memory that is disrupted by memory disorders like Alzheimer’s disease. The findings were published in The Journal of Neuroscience.
The prominent role a single enzyme plays in cancer imaging has eluded researchers for years, but not anymore. This discovery could pave new avenues in nuclear medicine.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
June 9, 2014 — ImaginAb Inc., in collaboration with Memorial Sloan-Kettering Cancer Center, will present at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) initial clinical data with an anti-PSMA (prostate-specific membrane antigen) recombinant antibody fragment (a "minibody") derived from the huJ591 monoclonal antibody, in patients with metastatic prostate cancer.
At the 2014 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 7-11, at the St. Louis Convention Center, Siemens Healthcare will debut syngo.via for molecular imaging — a reading solution that transforms large amounts of data into comprehensive results, allowing for organ-based reading [1], reference-based quantification [2] and evidence-based reporting [3] of disease.

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
At the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE Healthcare introduced its Discovery* IQ^ PET/CT (positron emission tomography/ computed tomography) system enabling both outstanding image quality and intelligent quantitation, helping physicians to deliver the best possible patient outcomes.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
A study of concussion patients using diffusion tensor imaging (DTI) found that males took longer to recover after concussion than females did. Results of the study, which show that DTI can be used as a bias-free way to predict concussion outcome, are published online in the journal Radiology.
Among the collection of aspiring medical isotope production companies looking to build facilities in the United States, Coquí RadioPharmaceuticals Corp. is he only one using a design and production method already proven in the commercial markets. Coquí is planning on constructing and operating a dedicated medical isotope production facility.
June 6, 2014 — Harvey L. Neiman, M.D., FACR, former chief executive officer of the American College of Radiology (ACR), died June 5 following a long illness. Neiman was widely considered a medical visionary who dedicated his professional life to improving patient care. “ACR members and staff, the radiology community, and organized medicine have lost a dear friend and colleague, exceptional leader, mentor and luminary,” said Bibb Allen, Jr., M.D., FACR, chair of the American College of Radiology Board of Chancellors.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
June 5, 2014 — Magnetic resonance-guided focused ultrasound (MRgFUS) using the Exablate system by Insightec Ltd. (based in Tirat Carmel, Israel) is a relatively new noninvasive thermal ablation option, U.S. Food and Drug Administration (FDA)-approved for treating and palliating pain from bone metastases. The technology integrates high-intensity focused ultrasound and a real-time magnetic resonance imaging (MRI) system in one unit.
June 5, 2014 — The American Society for Radiation Oncology (ASTRO) has garnered a record-breaking total of 2,874 abstracts submitted for selection for the 56th annual meeting. The scientific presentations will include up to four plenary papers, 360 oral presentations, 1,862 posters and 144 digital posters in more than 50 educational sessions and for 20 disease-site tracks and topics including radiation biology, radiation physics, palliative care, patient safety and patient-reported outcomes.
June 5, 2014 — A team of researchers at the University of Texas Health Science Center at Houston (UTHealth) Medical School has developed a new technology that can noninvasively image the human lymphatic system (also known as “lymphatics”). A fluorescent dye and commercially available laser diode and military-grade night vision devices were used to visualize the lymphatic capillaries.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
June 5, 2014 — Fairview Health Services, Minneapolis, recently became the first U.S. healthcare facility to install the Symbia Intevo xSPECT system from Siemens Healthcare. The first ever xSPECT system, the Symbia Intevo fully integrates single-photon emission computed tomography (SPECT) and CT during image reconstruction, combining SPECT’s high sensitivity with the high specificity of CT and completely integrating data from the two modalities to generate high resolution and, for the first time, quantitative images.
When a health insurance company denies a claim, most people complain to their friends and family and then accept it, arranging payment methods or even denying themselves a procedure that may save their life. However, one patient decided to fight back and challenge her insurance carrier.
The American Society for Radiation Oncology (ASTRO) has issued a new model policy for proton beam therapy (PBT) that details which cancer diagnoses meet ASTRO’s evidence-based standards and should be covered by private insurers and Medicare.
The U.S. Food and Drug Administration (FDA) recently cleared BB Medical Surgical’s Thixo-Gel, which is sprayed on to the patient to enable quicker and easier ultrasound scans.
Olympus announced the commercial availability of its U.S. Food and Drug Administration (FDA) 510(k)-cleared, next-generation BF-P190 and BF-XP190 bronchoscopes for peripheral and small anatomy bronchoscopy.
What started with a chug and a whisper is growing in both momentum and volume. Can you hear that whistle blowing?
The radiation therapy market, hit hard in 2009 by the recession, saw a sharp decline in purchasing from which it has slowly recovered. During the last five years the market has been steadily growing, with capital equipment budgets for radiation oncology sites increasing. However, it has only been within the last year that equipment purchases for radiation therapy have leveled out. Purchasing decisions today are driven by two main factors: advancements in technology, including more targeted treatment, multifunctional capabilities and improved patient safety; and the evolving reimbursement model, which weighs patient outcomes and the quality of care delivered more heavily.
June 3, 2014 — Elekta announced it signed an agreement to provide the Centre Hospitalier de l'Universite de Montreal (University of Montreal Health Centre, or CHUM) with advanced linear accelerators and software. The order, resulting from a competitive tender process, is valued at more than $20 million USD.